(E)-2-Methoxy-4-(3-(4-Methoxyphenyl) Prop-1-en-1-yl) Phenol Suppresses Breast Cancer Progression by Dual-Regulating VEGFR2 and PPARγ

키워드

참고문헌 (40)

1. Giaquinto AN, "Breast cancer statistics", CA Cancer J. Clin, 72, pp.524~541 (2022)
2. Waks AG, "Breast cancer treatment : a review", JAMA, 321, pp.288~300 (2019)
3. Raghavendra NM, "Dual or multi-targeting inhibitors : the next generation anticancer agents", Eur. J. Med. Chem, 143, pp.1277~1300 (2018)
4. Andreopoulou E, "Therapies for triple negative breast cancer", Exp. Opin. Pharmacother, 16, pp.983~998 (2015)
5. Lehmann JM, "An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma(PPAR gamma)", J. Biol. Chem, 270, pp.12953~12956 (1995)
6. Augimeri G, "The role of PPARgamma ligands in breast cancer : From basic research to clinical studies", Cancers(Basel), 12, pp.2623~ (2020)
7. Kim KY, "Anti-angiogenic action of PPARgamma ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation", Mol. Cell. Biochem, 358, pp.375~385 (2011)
8. Bhanushali U, "5-Benzylidene-2, 4-thiazolidenedione derivatives : design, synthesis and evaluation as inhibitors of angiogenesis targeting VEGR-2", Bioorg. Chem, 67, pp.139~147 (2016)
9. Guo S, "Vascular endothelial growth factor receptor-2 in breast cancer", Biochim. Biophys. Acta, 1806, pp.108~121 (2010)
10. Son DJ, "MMPP attenuates non-small cell lung cancer growth by inhibiting the STAT3 DNA-binding activity via direct binding to the STAT3 DNA-binding domain", Theranostics, 7, pp.4632~4642 (2017)
11. Kim NY, "MMPP promotes adipogenesis and glucose uptake via binding to the PPARgamma ligand binding domain in 3T3-L1 MBX cells", Front. Pharmacol, 13, pp.994584~ (2022)
12. Kim NY, "MMPP is a novel VEGFR2 inhibitor that suppresses angiogenesis via VEGFR2", AKT, NF-κB pathway, pp.BMB Rep, 2023[DOI]
13. Kim S, "MMPP exerts anti-inflammatory effects by suppressing MD2-dependent NF-kappaB and JNK", AP-1 pathways in THP-1 monocytes, 2023, pp.16, 480~
14. El-Adl K, "Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2, 4-dione derivatives targeting VEGFR-2 enzyme", Bioorg. Chem, 102, pp.104059~ (2020)
15. Son DJ, "Novel synthetic(E)-2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol inhibits arthritis by targeting signal transducer and activator of transcription 3", Sci. Rep, 6, pp.36852~ (2016)
16. Holliday DL, "Choosing the right cell line for breast cancer research", Breast Cancer Res, 13, pp.215~ (2011)
17. Kim NY, "Cinnamomum verum extract inhibits NOX2", ROS and PKCdelta, AP-1, pp.NF-kappaB pathway-mediated inflammatory response in PMA-stimulated THP-1 monocytes, Phytomedicine[DOI]
18. Upadhyay N, "Double-edged swords : diaryl pyrazoline thiazolidinediones synchronously targeting cancer epigenetics and angiogenesis", Bioorg. Chem, 116, pp.105350~ (2021)
19. Schneider CA, "NIH Image to ImageJ : 25 years of image analysis", Nat. Methods, 9, pp.671~675 (2012)
20. Lin PH, "TRC8 suppresses tumorigenesis through targeting heme oxygenase-1 for ubiquitination and degradation", Oncogene, 32, pp.2325~2334 (2013)
21. Klein CA, "Cancer progression and the invisible phase of metastatic colonization", Nat. Rev. Cancer, 20, pp.681~694 (2020)
22. Tao L, "Co-targeting cancer drug escape pathways confers clinical advantage for multitarget anticancer drugs", Pharmacol. Res, 102, pp.123~131 (2015)
23. Foulkes WD, "Triple-negative breast cancer", N. Engl. J. Med, 363, pp.1938~1948 (2010)
24. Fragomeni SM, "Molecular subtypes and local-regional control of breast cancer", Surg. Oncol. Clin. N. Am, 27, pp.95~120 (2018)
25. Moo TA, "Overview of breast cancer therapy", Pet Clin, 13, pp.339~354 (2018)
26. Ni H, "VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis", Cancer Biol. Med, 18, pp.139~154 (2021)
27. Yan JD, "Expression and prognostic significance of VEGFR-2 in breast cancer", Pathol. Res. Pract, 211, pp.539~543 (2015)
28. Mohan N, "A novel bispecific antibody targeting EGFR and VEGFR2 is effective against triple negative breast cancer via multiple mechanisms of action", Cancers(Basel), 13, pp.1027~ (2021)
29. Abhinand CS, "VEGF-A", VEGFR2 signaling network in endothelial cells relevant to angiogenesis, 2016, pp.10, 347~354
30. Spiegelman BM, "PPAR-gamma : adipogenic regulator and thiazolidinedione receptor", Diabetes, 47, pp.507~514 (1998)
31. Tontonoz P, "Adipocyte-specific transcription factor ARF6is a heterodimeric complex of two nuclear hormone receptors, PPAR gamma and RXR alpha", Nucleic Acids Res, 22, pp.5628~5634 (1994)
32. Carnero A, "The PTEN", PI3K, Curr. Cancer Drug Targets, pp.2008, 8[DOI]
33. Tang Z, "SALL4 activates PI3K", AKT signaling pathway through targeting PTEN, thus facilitating migration, invasion and proliferation of hepatocellular carcinoma cells, 2022, pp.14, 10081~10092
34. Peng C, "LRIG3 Suppresses angiogenesis by regulating the PI3K", AKT, Front. Oncol, pp.2021, 11[DOI]
35. Wang R, "Salvianolic acid A attenuates CCl(4)-induced liver fibrosis by regulating the PI3K", AKT, Bax and caspase-3, pp.cleaved caspase-3 signaling pathways, Drug Des. Devel. Ther[DOI]
36. Martinou JC, "Mitochondria in apoptosis : Bcl-2 family members and mitochondrial dynamics", Dev. Cell, 21, pp.92~101 (2011)
37. Cardone MH, "Regulation of cell death protease caspase-9 by phosphorylation", Science, 282, pp.1318~1321 (1998)
38. Slee EA, "Executioner caspase-3, -6, and-7 perform distinct, non-redundant roles during the demolition phase of apoptosis", J. Biol. Chem, 276, pp.7320~7326 (2001)
39. Huang Y, "RNF12 is regulated by AKT phosphorylation and promotes TGF-beta driven breast cancer metastasis", Cell Death Dis, 13, pp.44~ (2022)
40. Park M, "Breast cancer metastasis : mechanisms and therapeutic implications", Int. J. Mol. Sci, 23, pp.6806~ (2022)

관련 논문AI추천